CARBAPENEMASES AND GRAM-NEGATIVE BACTERIA: A REVIEW

Authors

  • Aishwarya J Ramalingam Bharath University

Abstract

ABSTRACT
The emergence of resistance in Gram-negative pathogens has alarmed many clinicians and health-care workers both in community and hospital
settings. Antibiotics, such as carbapenems, are used as a last resort in the treatment of multi-drug resistant (MDR) Gram-negative pathogens.
Carbapenemases are the enzymes that hydrolyze carbapenems. The global spread of these MDR organisms has posed a public health problem due to
its difficulty in empirical treatment of hospital and community acquired infections.
Keywords: Carbapenems, Carbapenemase, Gram-negative bacteria, Multi-drug resistant organisms.

Downloads

Download data is not yet available.

References

REFERENCES

Davies J, Davies D. Origins and evolution of antibiotic resistance.

Microbiol Mol Biol Rev 2010;74(3):417-33.

NDM-1

Sharma A. Antimicrobial resistance: No action today, no cure tomorrow.

Indian J Med Microbiol 2011;29(2):91-2.

Gaynes R, Edwards JR; National Nosocomial Infections Surveillance

System. Overview of nosocomial infections caused by Gram-negative

bacilli. Clin Infect Dis 2005;41(6):848-54.

Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing

Enterobacteriaceae. Emerg Infect Dis 2011;17(10):1791-8.

Dwivedi M, Mishra A, Azim A, Singh RK, Baronia AK, Prasad KN,

et al. Ventilator-associated pneumonia caused by carbapenem-resistant

Enterobacteriaceae carrying multiple metallo-beta-lactamase genes.

Indian J Pathol Microbiol 2009;52(3):339-42.

Rice LB. Federal funding for the study of antimicrobial

resistance in nosocomial pathogens: No ESKAPE. J Infect Dis

;197(8):1079-81.

Poole K. Overcoming multidrug resistance in Gram-negative bacteria.

Curr Opin Investig Drugs 2003;4(2):128-39.

Livermore DM. Defining an extended-spectrum beta-lactamase. Clin

Microbiol Infect 2008;14 Suppl 1:3-10.

Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable

resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in

clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Infection 1983;11(6):315-7.

Livermore DM. Carbapenemases. J Antimicrob Chemother

;29(6):609-13.

Walsh TR. Emerging carbapenemases: A global perspective. Int J

Antimicrob Agents 2010;36 Suppl 3:S8-14.

Bush K, Jacoby GA. Updated functional classification of

beta-lactamases. Antimicrob Agents Chemother 2010;54(3):969-76.

Kumarasamy KK, Toleman MA, Walsh TR, Bagaria T, Butt F,

Balakrishnan R, et al. Emergence of a new antibiotic resistance

mechanism in India, Pakistan, and the UK: A molecular, biological, and

epidemiological study. Lancet Infect Dis 2010;10:597-602.

Pitout JD. The latest threat in the war on antimicrobial resistance.

Lancet Infect Dis 2010;10(9):578-9.

Centers for Disease Control and Prevention, (CDC). Detection of

Enterobacteriaceae isolates carrying metallo-beta-lactamase - United

States 2010. Morb Mortal Wkly Rep 2010;59:750.

Xiang Z. China Reports First Cases of NDM-1 Super

Bacteria: 2010. Available from:

http://www.news.xinhuanet.com/english2010/

health/2010/10/26/c_13576388.htm.

Yuasa S. Japan Confirms First Case of Superbug Gene: 2010. Available

from: http://www.boston.com/news/health/articles/2010/09/08/japan_

confirms_first_case_of_superbug_gene/.

Tang KB, Ho KY. Superbug. 2010. Available from: http://www.hksccm.

org/attachments/article/2063/superbug%20Part%201.pdf.

Published

01-05-2016

How to Cite

Ramalingam, A. J. “CARBAPENEMASES AND GRAM-NEGATIVE BACTERIA: A REVIEW”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 3, May 2016, pp. 18-19, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/11017.

Issue

Section

Review Article(s)